Ct Lvas
Payments companies reported to CMS as associated with Ct Lvas. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Ct Lvas, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Ct Lvas
These are the largest totals companies reported as associated with Ct Lvas. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| David Shulkin | Morristown, NJ | Internal Medicine | $121,709.52 |
| Robert Figlin | Duarte, CA | Hematology & Oncology | $62,396.62 |
| Geraldine Mcginty | New York, NY | Diagnostic Radiology | $48,358.98 |
| Douglas Hogarth | Chicago, IL | Pulmonary Disease | $114.66 |
| Joseph Cicenia | Cleveland, OH | Pulmonary Disease | $95.61 |
| Michael Morris | Fort Sam Houston, TX | Pulmonary Disease | $94.00 |
| Christoph Wald | Rochester, MN | Diagnostic Radiology | $86.21 |
| Robert Miller | Nashville, TN | Pulmonary Disease | $70.91 |
| Myron Kung | North Las Vegas, NV | Pulmonary Disease | $70.00 |
| Raymond Casciari | Orange, CA | Pulmonary Disease | $67.50 |
Prescribed Ct Lvas?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.